Acinetobacter baumannii isolated from lebanese patients: Phenotypes and genotypes of resistance, clonality, and determinants of pathogenicity

Frontiers in Cellular and Infection Microbiology

Volumn 6, Issue NOV, 2016, Pages

  Dahdouh, Elias ^a   Hajjar, Micheline ^b   Suarez, Monica ^a   Daoud, Ziad ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF BALAMAND   (Lebanon)

Author keywords

Acinetobacter baumannii; Carbapenem resistance; Clonality; Oxacillinases; Virulence

Indexed keywords

CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMAZINE; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; SIDEROPHORE; ANTIINFECTIVE AGENT; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEM DERIVATIVE; CARBAPENEMASE; OXACILLINASE; PEPTIDE HYDROLASE; VIRULENCE FACTOR;

ACINETOBACTER BAUMANNII; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BIOFILM; CLONAL VARIATION; DISK DIFFUSION; GENE AMPLIFICATION; GENOTYPE; HEMOLYSIS; LEBANESE; MINIMUM INHIBITORY CONCENTRATION; PATHOGENICITY; PHENOTYPE; POLYMERASE CHAIN REACTION; PROTEIN DEGRADATION; ACINETOBACTER INFECTIONS; BACTERIUM IDENTIFICATION; BIOSYNTHESIS; CROSS INFECTION; DRUG EFFECTS; ENZYMOLOGY; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; ISOLATION AND PURIFICATION; LEBANON; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MULTIDRUG RESISTANCE; PROCEDURES; VIRULENCE;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; BETA-LACTAMASES; BIOFILMS; CARBAPENEMS; CROSS INFECTION; DISK DIFFUSION ANTIMICROBIAL TESTS; DNA, BACTERIAL; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GENOTYPE; HEMOLYSIS; HUMANS; LEBANON; MICROBIAL SENSITIVITY TESTS; PEPTIDE HYDROLASES; PHENOTYPE; POLYMERASE CHAIN REACTION; SIDEROPHORES; VIRULENCE; VIRULENCE FACTORS;

EID: 85006371239     PISSN: None     EISSN: 22352988     Source Type: Journal    
DOI: 10.3389/fcimb.2016.00163     Document Type: Article

References (47)

1. Antunes, L. C., Imperi, F., Carattoli, A., and Visca, P. (2011). Deciphering the multifactorial nature of Acinetobacter baumannii pathogenicity. PLoS ONE 6:e22674. doi: 10.1371/journal.pone.0022674
2. Antunes, L. C., Visca, P., and Towner, K. J. (2014). Acinetobacter baumannii: evolution of a global pathogen. Pathog. Dis. 71, 292-330. doi: 10.1111/2049-632X.12125
3. Beceiro, A., Tomás, M., and Bou, G. (2013). Antimicrobial resistance and virulence: a successful or deleterious association in the bacterial world? Clin. Microbiol. Rev. 26, 185-230. doi: 10.1128/CMR.00059-12
4. Bentancor, L. V., O'Malley, J. M., Bozkurt-Guzel, C., Pier, G. B., and Maira-Litrán, T. (2012). Poly-N-acetyl-β-(1-6)-glucosamine is a target for protective immunity against Acinetobacter baumannii infections. Infect. Immun. 80, 651-656. doi: 10.1128/IAI.05653-11
5. Bergen, P. J., Landersdorfer, C. B., Zhang, J., Zhao, M., Lee, H. J., Nation, R. L., and Li, J. (2012). Pharmacokinetics and pharmacodynamics of 'old' polymyxins: what is new? Diagn. Microbiol. Infect. Dis. 74, 213-223. doi: 10.1016/j.diagmicrobio.2012.07.010
6. Bonnin, R. A., Poirel, L., Licker, M., and Nordmann, P. (2011). Genetic diversity of carbapenem-hydrolysing β-lactamases in Acinetobacter baumannii from Romanian hospitals. Clin. Microbiol. Infect. 17, 1524-1528. doi: 10.1111/j.1469-0691.2011.03622.x
7. Breilh, D., Texier-Maugein, J., Allaouchiche, B., Saux, M. C., and Boselli, E. (2013). Carbapenems. J. Chemother. 25, 1-17. doi: 10.1179/1973947812Y.0000000032
8. Cerqueira, G. M., Kostoulias, X., Khoo, C., Aibinu, I., Qu, Y., Traven, A., et al. (2014). A global virulence regulator in Acinetobacter baumannii and its control of the phenylacetic acid catabolic pathway. J. Infect. Dis. 210, 46-55. doi: 10.1093/infdis/jiu024
9. Clemmer, K. M., Bonomo, R. A., and Rather, P. N. (2011). Genetic analysis of surface motility in Acinetobacter baumannii. Microbiology 157, 2534-2544. doi: 10.1099/mic.0.049791-0
10. Clinical Laboratory Standards Institute (2014). Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fourth Informational Supplement. M100-S24. Wayne, PA: Clinical and Laboratory Standards Institute.
11. Dahdouh, E., Orgaz, B., Gómez-Gil, R., Mingorance, J., Daoud, Z., Suarez, M., et al. (2016). Patterns of biofilm structure and formation kinetics among Acinetobacter baumannii clinical isolates with different antibiotic resistance profiles. Med. Chem. Commun. 7, 157-163. doi: 10.1039/C5MD00377F
12. Di Popolo, A., Giannouli, M., Triassi, M., Brisse, S., and Zarrilli, R. (2011). Molecular epidemiological investigation of multidrug-resistant Acinetobacter baumannii strains in four Mediterranean countries with a multilocus sequence typing scheme. Clin. Microbiol. Infect. 17, 197-201. doi: 10.1111/j.1469-0691.2010.03254.x
13. Eijkelkamp, B. A., Hassan, K. A., Paulsen, I. T., and Brown, M. H. (2011a). Investigation of the human pathogen Acinetobacter baumannii under iron limiting conditions. BMC Genomics. 12:126. doi: 10.1186/1471-2164-12-126
14. Eijkelkamp, B. A., Stroeher, U. H., Hassan, K. A., Papadimitrious, M. S., Paulsen, I. T., and Brown, M. H. (2011b). Adherence and motility characteristics of clinical Acinetobacter baumannii isolates. FEMS Microbiol. Lett. 323, 44-51. doi: 10.1111/j.1574-6968.2011.02362.x
15. Flamm, R. K., Castanheira, M., Streit, J. M., and Jones, R. N. (2016). Minocycline activity tested against Acinetobacter baumannii complex, Stenotrophomonas maltophilia, and Burkholderia cepacia species complex isolates from a global surveillance program (2013). Diagn. Microbiol. Infect. Dis. 85, 352-355. doi: 10.1016/j.diagmicrobio.2016.03.019
16. Gaddy, J. A., Arivett, B. A., McConnell, M. J., López-Rojas, R., Pachón, J., and Actis, L. A. (2012). Role of acinetobactin-mediated iron acquisition functions in the interaction of Acinetobacter baumannii strain ATCC 19606T with human lung epithelial cells, Galleria mellonella caterpillars, and mice. Infect. Immun. 80, 1015-1024. doi: 10.1128/IAI.06279-11
17. Gentile, V., Frangipani, E., Bonchi, C., Minandri, F., Runci, F., and Visca, P. (2014). Iron and Acinetobacter baumannii biofilm formation. Pathogens 3, 704-719. doi: 10.3390/pathogens3030704
18. Gordon, N. C., and Wareham, D. W. (2010). Multirdug-resistant Acinetobacter baumannii: mechanisms of virulence and resistance. Int. J. Antimicrob. Agents 35, 219-226. doi: 10.1016/j.ijantimicag.2009.10.024
19. Grosso, F., Quinteira, S., and Peixe, L. (2011). Understanding the dynamics of imipenem-resistant Acinetobacter baumannii lineages within Portugal. Clin. Microbiol. Infect. 17, 1275-1279. doi: 10.1111/j.1469-0691.2011.03469.x
20. Hall, B. G., Acar, H., Nandipati, A., and Barlow, M. (2014). Growth rates made easy. Mol. Biol. Evol. 31, 232-238. doi: 10.1093/molbev/mst187
21. Hammoudi, D., Moubareck, C. A., Hakime, N., Houmani, M., Barakat, A., Najjar, Z., et al. (2015a). Spread of imipenem-resistant Acinetobacter baumannii co-expressing OXA-23 and GES-11 carbapenemases in Lebanon. Int. J. Infect. Dis. 36, 56-61. doi: 10.1016/j.ijid.2015.05.015
22. Hammoudi, D., Moubareck, C. A., Kanso, A., Nordmann, P., and Sarkis, D. K. (2015b). Surveillance of carbapenem non-susceptible gram negative strains and characterization of carbapenems of classes A, B and D in a Lebanese hospital. Lebanese Med. J. 63, 66-73. doi: 10.12816/0012553
23. Hamouche, E., and Sarkis, D. K. (2012). [Evolution of susceptibility to antibiotics of Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa and Acinetobacter baumanii, in a University Hospital Center of Beirut between 2005 and 2009]. Pathol. Biol. 60, e15-e20. doi: 10.1016/j.patbio.2011.03.011
24. Karah, N., Sundsfjord, A., Towner, K., and Samuelsen, Ø. (2012). Insights into the global molecular epidemiology of carbapenem non-susceptible clones of Acinetobacter baumannii. Drug Resist. Updat. 15, 237-247. doi: 10.1016/j.drup.2012.06.001
25. Lemos, E. V., de la Hoz, F. P., Einarson, T. R., McGhan, W. F., Quevedo, E., Castañeda, C., et al. (2014). Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin. Microbiol. Infect. 20, 416-423. doi: 10.1111/1469-0691.12363
26. Louden, B. C., Haarmann, D., and Lynne, A. M. (2011). Use of blue agar CAS assay for siderophore detection. J. Microbiol. Biol. Educ. 12, 51-53. doi: 10.1128/jmbe.v12i1.249
27. Machuca, A., and Milagres, A. M. (2003). Use of CAS-agar plate modified to study the effect of different variables on the siderophore production by Aspergillus. Lett. Appl. Microbiol. 36, 177-181. doi: 10.1046/j.1472-765X.2003.01290.x
28. Mostachio, A. K., van der Heidjen, I., Rossi, F., Levin, A. S., and Costa, S. F. (2009). Multiplex PCR for rapid detection of genes encoding oxacillinases and metallo-beta-lactamases in carbapenem-resistant Acinetobacter spp. J. Med. Microbiol. 58, 1522-1524. doi: 10.1099/jmm.0.011080-0
29. Moubareck, C., Brémont, S., Conroy, M. C., Courvalin, P., and Lambert, T. (2009). GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob. Agents Chemother. 53, 3579-3581. doi: 10.1128/AAC.00072-09
30. Ñamendys-Silva, S. A., Correa-García, P., García-Guillén, F. J., González-Herrera, M. O., Pérez-Alonso, A., Texcocano-Becerra, J., et al. (2015). Outcomes of critically ill cancer patients with Acinetobacter baumannii infection. World J. Crit. Care Med. 4, 258-264. doi: 10.5492/wjccm.v4.i3.258
31. Nowak, P., and Paluchowska, P. (2016). Acinetobacter baumannii: biology and drug resistance-role of carbapenemases. Folia Histochem. Cytobiol. 54, 61-74. doi: 10.5603/FHC.a2016.0009
32. Peleg, A. Y., de Breij, A., Adams, M. D., Cerqueira, G. M., Mocali, S., Galardini, M., et al. (2012). The success of acinetobacter species; genetic, metabolic and virulence attributes. PLoS ONE 7:e46984. doi: 10.1371/journal.pone.0046984
33. Peleg, A. Y., Seifert, H., and Paterson, D. L. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin. Microbiol. Rev. 21, 538-582. doi: 10.1128/CMR.00058-07
34. Poirel, L., Walsh, T. R., Cuviller, V., and Nordmann, P. (2011). Multiplex PCR for detection of acquired carbapenemase genes. Diagn. Microbiol. Infect. Dis. 70, 119-123. doi: 10.1016/j.diagmicrobio.2010.12.002
35. Rafei, R., Dabboussi, F., Hamze, M., Eveillard, M., Lemarié, C., Gaultier, M. P., et al. (2014). Molecular analysis of Acinetobacter baumannii strains isolated in Lebanon using four different typing methods. PLoS ONE 9:e115969. doi: 10.1371/journal.pone.0115969
36. Rafei, R., Pailhoriés, H., Hamze, M., Eveillard, M., Mallat, H., Dabboussi, F., et al. (2015). Molecular epidemiology of Acinetobacter baumannii in different hospitals in Tripoli, Lebanon using bla(OXA-51-like) sequence based typing. BMC Microbiol. 15:103. doi: 10.1186/s12866-015-0441-5
37. Ronca-Testoni, S. (1983). Direct spectrophotometric assay for angiotensinconverting enzyme in serum. Clin. Chem. 29, 1093-1096.
38. Smith, M. G., Gianoulis, T. A., Pukatzki, S., Mekalanos, J. J., Ornston, L. N., Gerstein, M., et al. (2007). New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev. 21, 601-614. doi: 10.1101/gad.1510307
39. Tärnberg, M., Nilsson, L. E., and Dowzicky, M. J. (2016). Antimicrobial activity against a global collection of skin and skin structure pathogens: results from the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.), 2010-2014. Int. J. Infect. Dis. 49, 141-148. doi: 10.1016/j.ijid.2016.06.016
40. Taybali, A. F., Nguyen, K. C., Shwed, P. S., Crosthwait, J., Coleman, G., and Seligy, V. L. (2012). Comparison of the virulence potential of Acinetobacter strains from clinical and environmental sources. PLoS ONE 7:e37024. doi: 10.1371/journal.pone.0037024
41. Tomaras, A. P., Dorsey, C. W., Edelmann, R. E., and Actis, L. A. (2003). Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology. 149, 3473-3484. doi: 10.1099/mic.0.26541-0
42. Towner, K. J., Levi, K., Vlassiadi, M., and ARPA Steering Group (2008). Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin. Microbiol. Infect. 14, 161-167. doi: 10.1111/j.1469-0691.2007.01911.x
43. Turton, J. F., Gabriel, S. N., Valderrey, C., Kaufmann, M. E., and Pitt, T. L. (2007). Use of sequence-based typing and multiplex PCR to identify clonal lineages of outbreak strains of Acinetobacter baumannii. Clin. Microbiol. Infect. 13, 807-815. doi: 10.1111/j.1469-0691.2007.01759.x
44. Turton, J. F., Ward, M. E., Woodford, N., Kaufmann, M. E., Pike, R., Livermore, D. M., et al. (2006b). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol. Lett. 258, 72-77. doi: 10.1111/j.1574-6968.2006.00195.x
45. Turton, J. F., Woodford, N., Glover, J., Yarde, S., Kaufmann, M. E., and Pitt, T. L. (2006a). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44, 2974-2976. doi: 10.1128/JCM.01021-06
46. Valencia, R., Arroyo, L. A., Conde, M., Aldana, J. M., Torres, M. J., Fernández-Cuenca, F., et al. (2009). Nosocomial outbreak of infection with pan-drug resistant Acinetobacter baumannii in a tertiary care university hospital. Infect. Control Hosp. Epidemiol. 30, 257-263. doi: 10.1086/595977
47. Zarrilli, R., Vitale, D., Di Popolo, A., Bagattini, M., Daoud, Z., Khan, A. U., et al. (2008). A plasmid-borne blaOXA-58 gene confers imipenem resistance to Acinetobacter baumannii isolates from a Lebanese hospital. Antimicrob. Agents Chemother. 52, 4115-4120. doi: 10.1128/AAC.00366-08